The global antibiotic pipeline is running dry. How can Singapore spur new drug development? As bacterial infections become ever more challenging to cure, we should explore and contextualise incentives for antibiotic development, say NUS professors Hsu Li Yang, Wee Hwee Lin and Joanne Yoong.The global antibiotic development pipeline is stagnating, leading to a situation where bacterial infections are becoming ever more challenging to cure.
Imagine a world where bacterial infections are untreatable: A simple prick by a rose thorn, childbirth, or even the most minor surgery runs the risk of sepsis that no known drugs can cure. These scenarios have thankfully faded from common experience with the development of penicillin and other antibiotics since the 1940s —When faced with new antimicrobial agents, microbes like bacteria will adapt, eventually becoming resistant to the drugs. While this is a natural evolutionary process, the pace of antimicrobial resistance development has been rapidly accelerated by the breadth and depth of our collective human activit
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: TODAYonline - 🏆 1. / 99 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: straits_times - 🏆 5. / 69 Read more »
City Energy, Gentari to explore Malaysia-Singapore hydrogen pipelinepstrongThe parties will conduct the feasibility study over 12 months./strong/p pCity Energy and Gentari inked a Joint Feasibility Study Agreement to construct a pipeline from Malaysia to Singapore to import hydrogen./p pThe agreement follows a Memorandum of Understanding (MOU) signed in April 2023 between City Energy and Gentari.
Source: SBRMagazine - 🏆 13. / 51 Read more »